Waters (WAT) stock
Last close $440.45 on 2026-11-20 (-3.51%) · Sector: Healthcare
Waters Corporation is a Healthcare company that makes precision lab instruments, mainly chromatography and mass spectrometry systems that separate and measure the chemical parts of a sample. Its customers include drug makers, hospitals, food safety labs and environmental testers. It earns money from selling these instruments, along with the service contracts and lab supplies that go with them.
Waters has grown its quarterly revenue strongly over the past year, from $0.66 billion to $1.77 billion. Profit has been less steady, with two recent quarters of losses before a small profit returned in the latest one. The stock is up 11.8% over the past year, beating the S&P 500's 4.7% gain, and it sits 8.9% below its 52-week high. Its shares have moved sharply after earnings releases, rising after three of the last four, and a director sold $1.4 million of stock in August.
Key numbers
- Market cap: $43.6B
- Revenue (last 12 months): $5.49B
- Operating margin: 3.3%
- P/E: 415.5
- P/S: 7.9
- Debt to equity: 0.29
- Current ratio: 1.89
Quality score
Overall 29/100 · growth None · profitability 24 · financial health 64 · value 0
Performance and risk
1-year return +11.8% vs S&P 500 +4.7% · volatility 35.7% (S&P 500 14.3%) · largest drop -31.3% · beta 0.97
Stock move the day after earnings
- 2026-02-09: -13.9%
- 2026-05-05: +13.5%
- 2026-08-04: +5.7%
- 2026-11-03: +2.3%
Insider trades (12 months)
Bought $0.5M · sold $1.4M
WAT stock research · WAT options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.